Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brivaracetam add-on therapy in children and adolescents with focal seizures
CTR20252160Phase 3Completed
- Sponsor
- Jiangxi Kerui Pharmaceutical Co., Ltd.
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of brivaracetam in epilepsy, sponsored by Jiangxi Kerui Pharmaceutical Co., Ltd.. Started Aug 2025; status: completed.
02
Drugs
brivaracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on CTR20252160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252160.